[Pulmonary function tests on the bronchospasmolytic effect of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
D000368:Aged; D000403:Airway Resistance / Q000187:drug effects; D001991:Bronchitis / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000494:pharmacology*; D002908:Chronic Disease; D006801:Humans; D008168:Lung / Q000187:drug effects*; D009921:Metaproterenol / Q000494:pharmacology; D008875:Middle Aged; D010919:Placebos; D012129:Respiratory Function Tests; D013997:Time Factors; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014797:Vital Capacity / Q000187:drug effects; D014970:Xanthines / Q000494:pharmacology* / Q000627:therapeutic use
D001993:Bronchodilator Agents; D010919:Placebos; D014665:Vasodilator Agents; D014970:Xanthines; D009921:Metaproterenol
Lungenfunktionsuntersuchungen zur bronchospasmolytischen Wirkung von 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthin.